BD Biosciences contributions in CD4 counting and immune status for HIV/AIDS
Related Experiment Video
Updated: Sep 30, 2026
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Robert A Hoffman1, Vernon C Maino, Diether J Recktenwald
1BD Biosciences, 2350 Qume Drive, San Jose, CA 95131, USA. bhoffman@bdis.com
Abstract:
BD Biosciences is a leader in the use of flow cytometry for determining immune system status and for counting CD4 cells in patients with human immunodeficiency virus (HIV) infection. The company has gained this position through many years of basic research and product development in immunology and cell biology, dye chemistry, immunoassays, instrumentation, and software. Some of the highlights of these developments and their historical perspective are described in this review.
